On the reversal by (plus) and (minus)-propranolol of irreversible alpha-adrenoceptor blockade in rabbit aorta.
D000317:Adrenergic alpha-Antagonists / Q000037:antagonists & inhibitors*; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects*; D001665:Binding Sites / Q000187:drug effects; D001966:Bromine / Q000494:pharmacology; D002264:Carboxylic Acids / Q000494:pharmacology; D004123:Dimethylamines / Q000494:pharmacology; D005019:Ethyl Ethers / Q000494:pharmacology; D066298:In Vitro Techniques; D007536:Isomerism; D007546:Isoquinolines / Q000494:pharmacology; D008744:Methylamines / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009150:Mustard Compounds / Q000494:pharmacology; D009281:Naphthalenes / Q000494:pharmacology; D009638:Norepinephrine / Q000031:analogs & derivatives / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology*; D011817:Rabbits; D013015:Sotalol / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D002264:Carboxylic Acids; D004123:Dimethylamines; D005019:Ethyl Ethers; D007546:Isoquinolines; D008744:Methylamines; D009150:Mustard Compounds; D009281:Naphthalenes; D010627:Phenethylamines; D010643:Phenoxybenzamine; D011433:Propranolol; D013015:Sotalol; D001966:Bromine; D009638:Norepinephrine